China Jinmao Holdings Group Ltd. (FRSHY: Pink Current) | Scheduled Ex-Dividend

Cannabis Global Discusses its Expected 50%+ Cost Advantage in THC-V and Other Exotic Cannabinoids for Beverage and Food Produ…

Cannabis Global Discusses its Expected 50%+ Cost Advantage in THC-V and Other Exotic Cannabinoids for Beverage and Food Products   LOS ANGELES, CA — June 03, 2020 — InvestorsHub NewsWire — Cannabis Global, Inc. (OTC: MCTC) (“Cannabis Global” or the “Company”), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today provides…

Pressure BioSciences Announces Launch of Novel, FDA Registered Immune Booster by Pending Merger Partner Cannaworx, Inc.

Pressure BioSciences Announces Launch of Novel, FDA Registered Immune Booster by Pending Merger Partner Cannaworx, Inc.

  Patented and Proprietary, the Company’s Immune Booster is One of Very Few Hemp-Enhanced, FDA Registered Products with a Claim for Boosting the Immune System’s Effectiveness Against Invading Pathogens South Easton, MA, May 28, 2020 – InvestorsHub NewsWire — Pressure BioSciences, Inc. — (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale…

Financial Gravity: ‘’We are preparing for great expansion during the next few years and are amazed at the momentum that has kicked in already.’’
FGCO

What do they mean by preparing for the great expansion during the next few years? Well the company Financial Gravity Inc. has a disruptive business model by acquiring financial services and apply their talent and knowledge to it. Bringing them all together to provide the best financial services to their clients in terms of brokerage,…

Click Here for more Pressure Biosciences (QB) Charts.

Pressure BioSciences Announces Launch of FDA-Registered Hand Sanitizer as First Product Developed Through Pending Merger Part…

Pressure BioSciences Announces Launch of FDA-Registered Hand Sanitizer as First Product Developed Through Pending Merger Partners  South Easton, MA — May 14, 2020 — InvestorsHub NewsWire — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide…

Click Here for more Revive Therapeutics Charts.

Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial

TORONTO, Canada — April 23, 2020 — InvestorsHub NewsWire — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that it has received positive feedback from the U.S. Food and Drug Administration (“FDA”) in…